Case Reports

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester
Division of Hematology/Oncology, Sanford Cancer Center, Sioux Falls, SD USA
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester
Department of Laboratory medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester
Department of Laboratory medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester
Vol. 109 No. 2 (2024): February, 2024 https://doi.org/10.3324/haematol.2023.283740